Salta al contenuto principale

Spinal muscular atrophy with respiratory distress type 1

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an inherited condition that causes muscle weakness and respiratory failure typically beginning in infancy. Early features of this condition are difficult and noisy breathing, especially when inhaling; a weak cry; problems feeding; and recurrent episodes of pneumonia. Typically between the ages of 6 weeks and 6 months, infants with this condition will experience a sudden inability to breathe due to paralysis of the muscle that separates the abdomen from the chest cavity (the diaphragm). Normally, the diaphragm contracts and moves downward during inhalation to allow the lungs to expand. With diaphragm paralysis, affected individuals require life-long support with a machine to help them breathe (mechanical ventilation). Rarely, children with SMARD1 develop signs or symptoms of the disorder later in childhood.

Descrizione

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an inherited condition that causes muscle weakness and respiratory failure typically beginning in infancy. Early features of this condition are difficult and noisy breathing, especially when inhaling; a weak cry; problems feeding; and recurrent episodes of pneumonia. Typically between the ages of 6 weeks and 6 months, infants with this condition will experience a sudden inability to breathe due to paralysis of the muscle that separates the abdomen from the chest cavity (the diaphragm). Normally, the diaphragm contracts and moves downward during inhalation to allow the lungs to expand. With diaphragm paralysis, affected individuals require life-long support with a machine to help them breathe (mechanical ventilation). Rarely, children with SMARD1 develop signs or symptoms of the disorder later in childhood.

Soon after respiratory failure occurs, individuals with SMARD1 develop muscle weakness in their distal muscles. These are the muscles farther from the center of the body, such as muscles in the hands and feet. The weakness soon spreads to all muscles; however, within 2 years, the muscle weakness typically stops getting worse. Some individuals may retain a low level of muscle function, while others lose all ability to move their muscles. Muscle weakness severely impairs motor development, such as sitting, standing, and walking. Some affected children develop an abnormal side-to-side and back-to-front curvature of the spine (scoliosis and kyphosis, often called kyphoscoliosis when they occur together). After approximately the first year of life, individuals with SMARD1 may lose their deep tendon reflexes, such as the reflex being tested when a doctor taps the knee with a hammer.

Other features of SMARD1 can include reduced pain sensitivity, excessive sweating (hyperhidrosis), loss of bladder and bowel control, and an irregular heartbeat (arrhythmia).

Modelli di ereditarietà

The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.

Altri nomi

Autosomal recessive distal spinal muscular atrophy 1

DHMN6

Diaphragmatic spinal muscular atrophy

Distal hereditary motor neuronopathy type VI

Distal spinal muscular atrophy type 1

DSMA1

HMN6

HMNVI

Severe infantile axonal neuropathy with respiratory failure

SIANRF

SMARD1

Spinal muscular atrophy with respiratory distress

Related patient information and medicines

Insufficienza respiratoria

Patient information leaflet

Insufficienza respiratoria

Pulmonary fibrosis . Asthma. Pneumothorax . Pulmonary embolism. Pulmonary hypertension (high blood pressure in the blood vessels that supply the lungs). Bronchiectasis. Acute respiratory distress syndrome (ARDS): a life-threatening condition in which the lungs are unable to provide enough oxygen. It usually occurs as a complication of a serious.

distrofia muscolare di Duchenne

Patient information leaflet

distrofia muscolare di Duchenne

distrofia muscolare di Duchenne is a condition which causes progressive muscle weakness. It starts in childhood and may be noticed when a child has difficulty standing up, climbing or running. Duchenne muscular dystrophy (DMD) è an inherited (genetic) condition which affects muscle strength and function. It causes progressive muscle weakness and is a.

Distrofia muscolare

Patient information leaflet

Distrofia muscolare

Distrofia muscolare is an inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, ranging from very mild to severe. The different types also vary as to what age t... What is muscular dystrophy. Muscular dystrophy (MD) is the name given to a group of Sintomi dei disturbi della tiroide which.

Problemi ai dischi spinali

Patient information leaflet

Problemi ai dischi spinali

Spinal discs are also called intervertebral discs. There is a spinal disc between each bone (vertebra) in your spine. This keeps the vertebrae separated and acts as a shock absorber. As we get older the spinal discs gradually become damaged and this can cause problems such as back pain. Other problems affecting the spinal discs include a slipped.

Anestetico spinale

Patient information leaflet

Anestetico spinale

A spinal anaesthetic is an alternative to a general anaesthetic for some operations. What is a spinal anaesthetic. This is where the anaesthetist gives the patient medication, usually through a drip (cannula) into a vein, and sends them off to sleep. A breathing tube is inserted after the patient is asleep so the breathing can be controlled.

Cancro del rene

Patient information leaflet

Cancro del rene

La maggior parte cases of kidney cancer develop in le persone between the ages of 60 and 70 although it can affect any age group. If kidney cancer is diagnosed at an early stage, there is a good chance of a cure. A description of what kidneys are and how they work is at the bottom of this article. What is kidney cancer. There are several types of kidney cancer.

Ulteriori letture e riferimenti

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
  • 18 Ago 2020 | Ultima versione
  • 1 Jan 2013 | Pubblicato originariamente

Partecipa alla conversazione

Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.

Avvertenza: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.
verifica idoneità al vaccino antinfluenzale

Chiedi, condividi, connettiti.

Esplora le discussioni, fai domande e condividi esperienze su centinaia di argomenti di salute.

Iscriviti alla newsletter di Patient

La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.

Per favore, inserisci un indirizzo email valido

Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.